Atherosclerotic Disease Clinical Trials

7 recruitingLast updated: June 18, 2026

There are 7 actively recruiting atherosclerotic disease clinical trials across 7 countries. Studies span Not Applicable, Phase 2, Phase 3. Top locations include Baotou, Inner Mongolia, China, Beijing, Beijing Municipality, China, Benxi, Liaoning, China. Updated daily from ClinicalTrials.gov.


Atherosclerotic Disease Trials at a Glance

7 actively recruiting trials for atherosclerotic disease are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Baotou, Beijing, and Benxi. Lead sponsors running atherosclerotic disease studies include Beijing Inno Medicine Co., Ltd., Beijing Tiantan Hospital, and Baylor Research Institute.

Browse atherosclerotic disease trials by phase

Treatments under study

About Atherosclerotic Disease Clinical Trials

Looking for clinical trials for Atherosclerotic Disease? There are currently 2 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Atherosclerotic Disease trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Atherosclerotic Disease clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Pemafibrate for Symptomatic ICAS RCT

HypertriglyceridaemiaStroke (CVA) or TIAIntracranial Atherosclerotic Disease (ICAD)
Tokyo Women's Medical University270 enrolled19 locationsNCT07562178
Recruiting

Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)

Heart FailureSarcopeniaOsteoporosis+11 more
Bettina Mittendorfer100 enrolled1 locationNCT07083557
Recruiting
Phase 2

YN001-004 in Patients With Coronary Atherosclerosis in Australia

Coronary Artery DiseaseCoronary Atherosclerotic Disease
Beijing Inno Medicine Co., Ltd.24 enrolled7 locationsNCT06700720
Recruiting

Endovascular Recanalization for Symptomatic Chronic Intradural Occlusions

Intracranial StenosisIntracranial Atherosclerotic Disease
Insel Gruppe AG, University Hospital Bern80 enrolled2 locationsNCT07072026
Recruiting
Not Applicable

Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

StrokeICAD - Intracranial Atherosclerotic DiseaseICAS - Intracranial Atherosclerosis+3 more
Beijing Tiantan Hospital792 enrolled18 locationsNCT04948749
Recruiting
Phase 2

Colchicine Use in Intracranial Atherosclerotic Disease

ICAD - Intracranial Atherosclerotic Disease
Chinese University of Hong Kong72 enrolled1 locationNCT05503225
Recruiting
Phase 3

Alirocumab in Patients on a Stable Dialysis Regimen

Peritoneal DialysisHemodialysisAtherosclerotic Disease+1 more
Baylor Research Institute20 enrolled1 locationNCT03480568